4
Participants
Start Date
September 30, 2019
Primary Completion Date
December 31, 2022
Study Completion Date
December 31, 2026
Deep Brain Simulator
This is an open-label, safety, tolerability, and feasibility study for participants who have treatment refractory OUD that are eligible to have DBS targeting the NAc/VC.
West Virginia University Rockefeller Neuroscience Institute, Morgantown
Collaborators (1)
National Institute on Drug Abuse (NIDA)
NIH
Medtronic
INDUSTRY
West Virginia University
OTHER